These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31744356)

  • 1. Patterns of care for women with placenta accreta spectrum.
    Couret M; Huang Y; Khoury-Collado F; Friedman A; Hou JY; St Clair CM; Tergas AI; Ananth CV; Wright JD
    J Matern Fetal Neonatal Med; 2021 Oct; 34(20):3370-3376. PubMed ID: 31744356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: A prospective population-based cohort study.
    Ornaghi S; Maraschini A; Donati S;
    PLoS One; 2021; 16(6):e0252654. PubMed ID: 34086797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
    Sentilhes L; Seco A; Azria E; Beucher G; Bonnet MP; Branger B; Carbillon L; Chiesa C; Crenn-Hebert C; Dreyfus M; Dupont C; Fresson J; Huissoud C; Langer B; Morel O; Patrier S; Perrotin F; Raynal P; Rozenberg P; Rudigoz RC; Vendittelli F; Winer N; Deneux-Tharaux C; Kayem G;
    Am J Obstet Gynecol; 2022 Jun; 226(6):839.e1-839.e24. PubMed ID: 34914894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital surgical volume-outcome relationship in caesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Youssefzadeh AC; Mandelbaum RS; Sangara RN; Matsuzaki S; Matsushima K; Klar M; Ouzounian JG; Wright JD
    BJOG; 2022 May; 129(6):986-993. PubMed ID: 34743389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 9. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.
    McCall SJ; Deneux-Tharaux C; Sentilhes L; Ramakrishnan R; Collins SL; Seco A; Kurinczuk JJ; Knight M; Kayem G
    BJOG; 2022 Sep; 129(10):1676-1685. PubMed ID: 35384244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study.
    Morlando M; Schwickert A; Stefanovic V; Gziri MM; Pateisky P; Chalubinski KM; Nonnenmacher A; Morel O; Braun T; Bertholdt C; Van Beekhuizen HJ; Collins SL;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():41-49. PubMed ID: 33713033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
    Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planned versus Unplanned Delivery for Placenta Accreta Spectrum.
    Fishel Bartal M; Papanna R; Zacharias NM; Soriano-Calderon N; Limas M; Blackwell SC; Chen HY; Chauhan SP; Sibai BM
    Am J Perinatol; 2022 Feb; 39(3):252-258. PubMed ID: 32702770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of a False-Positive Antenatal Diagnosis of Placenta Accreta Spectrum.
    Salmanian B; Shamshirsaz AA; Fox KA; Asl NM; Erfani H; Detlefs SE; Coburn M; Espinoza J; Nassr A; Belfort MA; Clark SL; Shamshirsaz AA
    Am J Perinatol; 2024 Jan; 41(2):187-192. PubMed ID: 34666389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of prophylactic balloon occlusion in the management of placenta accreta spectrum disorder: a retrospective cohort study.
    Chen K; Chen J; Ma Y; Gan Y; Huang L; Yang F; Chen Y; Zhong L; Su S; Long Y
    BMC Womens Health; 2024 Apr; 24(1):208. PubMed ID: 38561713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Severe Maternal Morbidity in Patients with Placenta Accreta Spectrum Disorders Referred from Rural Communities to a Regional Placenta Accreta Spectrum Center.
    Munoz JL; Ramsey PS; Byrne JJ
    Am J Perinatol; 2023 Dec; 40(16):1738-1744. PubMed ID: 37433315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
    van Beekhuizen HJ; Stefanovic V; Schwickert A; Henrich W; Fox KA; MHallem Gziri M; Sentilhes L; Gronbeck L; Chantraine F; Morel O; Bertholdt C; Braun T; Rijken MJ; Duvekot JJ;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1(Suppl 1):12-20. PubMed ID: 33483943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.